VYEPTI 100 mg concentrate for solution for infusion

Licence status
Authorised: 24/01/2022
Active substances
Eptinezumab
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/21/1599/001
Licence holder
H. Lundbeck A/S

Product documents

Licence information

ATC code
N02C ANTIMIGRAINE PREPARATIONS, N02CD05 eptinezumab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
24/01/2022